Kardigan, Inc. (KARD) Revenue, Earnings & Financial Statements
$13.19NASDAQ: KARDMarket Cap $1.18B
Data as of Nov 17, 2026 close · Statements through the quarter ended Sep 2026 · Source: Financial Modeling Prep (methodology)
Kardigan, Inc. most recently reported annual revenue of $0, a net loss of $192.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Income Statement — 1 Years (USD millions)
Metric
2025
Revenue
$0
Operating Expenses
$202.0M
Operating Profit
−$202.0M
Other Income
$5.0M
Interest
$0
Depreciation
$6.0M
Profit Before Tax
−$196.0M
Tax rate (%)
2.3%
Net Profit
−$192.0M
EPS
−$3.20
Quarterly Results — Last 3 Quarters (USD millions)
Metric
Mar '26
Jun '26
Sep '26
Revenue
$0
$0
$0
Operating Expenses
$59.0M
$75.0M
$87.0M
Operating Profit
−$59.0M
−$75.0M
−$87.0M
Interest
$0
$0
$0
Profit Before Tax
−$56.0M
−$116.0M
−$59.0M
Tax rate (%)
0.0%
0.0%
0.0%
Net Profit
−$56.0M
−$116.0M
−$59.0M
EPS
−$0.90
−$1.24
−$0.64
Balance Sheet — 1 Years (USD millions)
Metric
2025
Total Assets
$391.0M
Current Assets
$345.0M
Cash
$109.0M
Inventory
$0
Receivables
$0
Fixed Assets
$18.0M
Capital Work in Progress
$0
Investments
$226.0M
Other Assets
$0
Total Liabilities
$641.0M
Current Liabilities
$38.0M
Borrowings
$14.0M
Other Liabilities
$627.0M
Equity
$0
Reserves
−$250.0M
Cash Flow Statement — 1 Years (USD millions)
Metric
2025
Operating Cash Flow
−$151.0M
Investing Cash Flow
−$244.0M
Financing Cash Flow
−$6.0M
Net Cash Flow
$60.0M
Free Cash Flow
−$158.0M
Valuation & Return Ratios
Metric
Value
PEG Ratio
-0.05
EV / EBITDA
-5.20
FCF Yield
-14.41%
Quick Ratio
10.62
Interest Coverage
—
Return 1Y
—
Return 3Y
—
Return 5Y
—
Kardigan, Inc. (KARD) financials — frequently asked questions
What is Kardigan, Inc.'s annual revenue?
Kardigan, Inc. (KARD) reported annual revenue of $0 in its most recent fiscal year.
What is Kardigan, Inc.'s net profit?
Kardigan, Inc. (KARD) reported a net loss of $192.0M in its most recent fiscal year.
What is KARD EV/EBITDA?
Kardigan, Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is -5.20. A negative value means EBITDA was negative over the period, so the ratio is not a meaningful valuation measure.
Revenue and earnings of other Biotechnology stocks